You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for CALCIUM ANTACID


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CALCIUM ANTACID

Average Pharmacy Cost for CALCIUM ANTACID

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CALCIUM ANTACID 750 MG CHEW TAB 00536-1225-22 0.03230 EACH 2024-12-18
CALCIUM ANTACID 500 MG CHW TAB 00904-6412-92 0.01673 EACH 2024-12-18
CALCIUM ANTACID 500 MG CHW TAB 00536-1048-15 0.01673 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

CALCIUM ANTACID Market Analysis and Financial Projection

Global Calcium Antacid Market Analysis and Price Projections

Market Overview

The global antacid market, which includes calcium antacids, is experiencing significant growth driven by increasing cases of gastrointestinal disorders, acid reflux, and heartburn. Here’s a comprehensive analysis of the market and price projections for calcium antacids.

Market Size and Growth

The global antacid market is substantial and growing steadily. As of 2024, the market size is estimated to be around USD 7.40 billion to USD 9.16 billion, depending on the source[3][4].

  • By 2031, the market is projected to reach USD 9.29 billion to USD 9.64 billion, with a Compound Annual Growth Rate (CAGR) of 3.3% to 3.9%[3][4].
  • Another projection suggests the market could expand to USD 11 billion by 2028 at a CAGR of 3.7%[4].

Regional Market Analysis

North America

North America dominates the global antacid market, accounting for over 40% of the global revenue. This is due to high disposable income, an aging population, and a well-established healthcare system. The market size in North America was estimated at USD 2.5 billion in 2024 and is expected to grow at a CAGR of 3.7% from 2024 to 2031[1].

Europe

Europe holds around 30% of the global antacid market revenue, with a market size of USD 1.875 billion in 2024. The region is expected to grow at a CAGR of 4.0% from 2024 to 2031[1].

Asia Pacific

The Asia Pacific region is expected to be the fastest-growing market, driven by high unmet clinical needs, efficient treatment options, rising disposable income, and increasing consumer awareness. The market size in this region was around USD 1.437 billion in 2024 and is projected to grow at a CAGR of 7.5% from 2024 to 2031[1].

Latin America and Middle East & Africa

Latin America and the Middle East & Africa also contribute to the global market, though to a lesser extent. Latin America held around 5% of the global revenue with a market size of USD 312.58 million in 2024, growing at a CAGR of 4.9%. The Middle East and Africa held around 2% with a market size of USD 125.03 million in 2024, growing at a CAGR of 5.2% from 2024 to 2031[1].

Key Drivers of Growth

Increasing Prevalence of Gastrointestinal Disorders

The rising incidence of heartburn, GERD, and other digestive disorders is a significant driver of the antacid market. Approximately 784 million individuals worldwide are affected by these conditions, driving the demand for antacids[3].

Lifestyle Changes and Dietary Habits

Changes in lifestyle and dietary habits, such as increased consumption of spicy and fatty foods, contribute to the growing need for antacids. Economic conditions, historical dietary shifts, and medical advancements also play crucial roles[4].

Technological Advancements and Consumer Preferences

Technological advancements in the formulation of antacids, such as the development of more effective and safer products, are driving market growth. Consumer preferences for natural remedies and the rise of online pharmacies are also significant factors[5].

Price Projections for Calcium Antacids

Raw Material Costs

Calcium carbonate, a key ingredient in many antacids, has seen fluctuating prices due to various market dynamics. In the Asia-Pacific region, the price of calcium carbonate has been affected by factors such as seasonal demands, construction sector activities, and supply chain disruptions. For instance, in the second quarter of 2024, prices in Asia saw a wavering pattern due to the Chinese market's off-season and high inventories[2].

Market Pricing Trends

The overall pricing of antacids, including those containing calcium, is influenced by the cost of raw materials, production costs, and market demand. Given the steady demand for antacids and the expected growth in the market, prices are likely to remain stable or see a moderate increase.

Regional Price Variations

Prices can vary significantly by region due to different market conditions and regulatory environments. For example, in North America, the well-established healthcare system and high disposable income support higher pricing compared to other regions[1].

Segmentation and Market Insights

Type Outlook

The antacid market is segmented based on type, dosage form, and route of administration. Tablets account for a significant share of the market, with around 50% of the global market in 2023[5].

Dosage Form Outlook

Antacids are available in various forms, including tablets, powders, and liquids. Each form has its own market share and growth prospects, with tablets being the most popular due to their ease of use and effectiveness[5].

Route of Administration Outlook

The route of administration, whether oral or other, also influences market segmentation. Oral antacids are the most common and are expected to continue dominating the market[1].

Key Takeaways

  • The global antacid market, including calcium antacids, is projected to grow significantly due to increasing cases of gastrointestinal disorders.
  • North America and Europe are major markets, but the Asia Pacific region is expected to grow the fastest.
  • The market is driven by lifestyle changes, technological advancements, and consumer preferences.
  • Prices of calcium antacids are influenced by raw material costs, production costs, and regional market dynamics.
  • The market is segmented by type, dosage form, and route of administration, with tablets being the most popular form.

FAQs

Q: What is the current size of the global antacid market?

The global antacid market size is estimated to be around USD 7.40 billion to USD 9.16 billion in 2024[3][4].

Q: What is the expected growth rate of the global antacid market?

The market is expected to grow at a CAGR of 3.3% to 3.9% from 2024 to 2031[3][4].

Q: Which region is expected to be the fastest-growing market for antacids?

The Asia Pacific region is expected to be the fastest-growing market, driven by high unmet clinical needs and rising disposable income[1].

Q: What are the key drivers of the antacid market?

Key drivers include the increasing prevalence of gastrointestinal disorders, lifestyle changes, technological advancements, and consumer preferences for natural remedies[3][4][5].

Q: How do raw material costs affect the pricing of calcium antacids?

Raw material costs, such as the price of calcium carbonate, can fluctuate due to market dynamics and affect the overall pricing of antacids. For example, seasonal demands and supply chain disruptions can impact prices[2].

Sources

  1. Cognitive Market Research: Global Antacid Market Report 2024.
  2. Procurement Resource: Calcium Carbonate Price Trend, Chart, Market Analysis.
  3. GlobeNewswire: Antacids Market Size Expected to Reach USD 9.64 Bn by 2032.
  4. The Business Research Company: Antacids Global Market Report 2024.
  5. Fact.MR: Antacids Market Size, Share, Demand & Growth Analysis, 2033.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.